A detailed history of State Of Wisconsin Investment Board transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 41,360 shares of CLDX stock, worth $1.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,360
Previous 36,770 12.48%
Holding current value
$1.08 Million
Previous $1.36 Million 3.24%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$32.06 - $44.56 $147,155 - $204,530
4,590 Added 12.48%
41,360 $1.4 Million
Q2 2024

Aug 14, 2024

BUY
$32.76 - $42.56 $17,624 - $22,897
538 Added 1.48%
36,770 $1.36 Million
Q1 2024

May 14, 2024

SELL
$35.22 - $51.88 $150,952 - $222,357
-4,286 Reduced 10.58%
36,232 $1.52 Million
Q4 2023

Feb 12, 2024

BUY
$22.61 - $40.65 $193,745 - $348,329
8,569 Added 26.82%
40,518 $1.61 Million
Q3 2023

Nov 14, 2023

SELL
$25.45 - $37.46 $31,507 - $46,375
-1,238 Reduced 3.73%
31,949 $879,000
Q2 2023

Aug 14, 2023

SELL
$30.29 - $38.28 $141,696 - $179,073
-4,678 Reduced 12.35%
33,187 $1.13 Million
Q1 2023

May 15, 2023

BUY
$34.78 - $47.43 $10,399 - $14,181
299 Added 0.8%
37,865 $1.36 Million
Q4 2022

Feb 14, 2023

SELL
$27.78 - $45.38 $11,500 - $18,787
-414 Reduced 1.09%
37,566 $1.67 Million
Q3 2022

Nov 14, 2022

SELL
$22.7 - $37.57 $52,641 - $87,124
-2,319 Reduced 5.75%
37,980 $1.07 Million
Q2 2022

Aug 15, 2022

SELL
$20.5 - $37.33 $436,670 - $795,166
-21,301 Reduced 34.58%
40,299 $1.09 Million
Q1 2022

May 13, 2022

BUY
$27.64 - $39.32 $301,276 - $428,588
10,900 Added 21.5%
61,600 $2.1 Million
Q3 2021

Nov 12, 2021

BUY
$28.95 - $55.99 $28,950 - $55,990
1,000 Added 2.01%
50,700 $2.74 Million
Q2 2021

Aug 12, 2021

BUY
$20.71 - $35.37 $1.03 Million - $1.76 Million
49,700 New
49,700 $1.66 Million

Others Institutions Holding CLDX

About Celldex Therapeutics, Inc.


  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.23B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.